← FDA Drug Approvals (Drugs@FDA)

DEFERASIROX

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA · Approved 2022-09-23

Drug application

FDA Application #

ANDA207124

Application type

Abbreviated New Drug Application (Generic)

Brand name

DEFERASIROX

Generic name

DEFERASIROX

Active ingredients

DEFERASIROX

Dosage form

TABLET, FOR SUSPENSION

Route

ORAL

Marketing status

Prescription

Sponsor

TEVA PHARMS USA

Manufacturer

Teva Pharmaceuticals, Inc.

First approval

2022-09-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown